See also this year's filing and all EDGAR filings for this company.
PDF Report 0001343009_2024_CNBX_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'ComprehensiveNetIncome', 'value': -695198, 'size_variable': 'Assets', 'size_value': 31383, 'ratio': 22.2, 'threshold': 20} |
Graph
Absolute values for 0001343009, CNBX Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 224,308 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 274,731 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,516,328 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,025,651 |
| 9 | ResearchAndDevelopmentExpense | -1,358,467 |
| 10 | remainder_Expenses | 477,993 |
| 11 | remainder_Revenues | 476,207 |
| 12 | remainder_NetIncome | -1,580,227 |
| 13 | remainder_ComprehensiveNetIncome | -337,522 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 499,039 |
| 1 | Liabilities | 2,516,328 |
| 2 | Expenses | 145,177 |
| 3 | Revenues | 476,207 |
| 4 | StockholdersEquity | -2,017,289 |
| 5 | NetIncome | -1,249,197 |
| 6 | ComprehensiveNetIncome | -1,417,958 |
| 7 | BaseVar | 2,777,250 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.86 |
| 9 | EconomicCapitalRatio | 0.429 |
Edgar->Model Mapping
Feature Distribution
Change over Time
